Inactive Instrument

Tandem Diabetes Care Inc Stock Nasdaq

Equities

US8753721047

Medical Equipment, Supplies & Distribution

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 870M Sales 2025 * 959M Capitalization 2.72B
Net income 2024 * -105M Net income 2025 * -71M EV / Sales 2024 * 2.96 x
Net cash position 2024 * 145M Net cash position 2025 * 111M EV / Sales 2025 * 2.72 x
P/E ratio 2024 *
-27.3 x
P/E ratio 2025 *
-40.9 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.35%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 68 13-02-28
Director of Finance/CFO 51 13-08-31
Compliance Officer 58 21-12-31
Members of the board TitleAgeSince
Chairman 63 19-01-02
Director/Board Member 64 13-06-30
Director/Board Member 71 07-08-31
More insiders
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW